Success Stories: EB-1B Petition Approved in Only 7 Days for Indian Chemical Engineering Senior Scientist based in California

Client’s Testimonial:

“Thank you very much for the notification about my EB1B approval. I was not expecting a decision this soon! It is a huge relief for me and this approval was essential for personal and professional reasons. I want to sincerely thank your entire team very much for your expertise, knowledge and hard work that made this case successful. “

On July 15^th, 2019, we received another EB1-B (Outstanding Professors and Researchers) approval for a Senior Scientist in the Field of Chemical Engineering (Approval Notice).

General Field: Chemical Engineering

Position at the Time of Case Filing: Senior Scientist

Country of Origin: India

State of Residence at the Time of Filing: California

Approval Notice Date: July 15^th, 2019

Processing Time: 7 Days (Premium Processing Requested)

Case Summary:

A senior scientist from India hired North America Immigration Law Group
(WeGreened.com) to build a customized EB-1B (Outstanding Professors and Researchers) petition for him. Thanks to Premium Processing (PP), it took USCIS merely 7 days to adjudicate our client’s petition. Not only did our client hold strong credentials, he also had full support from his employer to serve as the case petitioner.

Our client’s specialized research has focused on computational modeling, which includes modeling polymer photovoltaics, understanding and predicting self-assembly in complex block copolymers, modeling semicrystalline polymers for high-strength materials, studying the nucleation and crystallization of small particles for pharmaceutical applications, and making contributions to dynamic modeling and optimization of chemical and industrial processes. His findings have made substantial impact on the field of chemical engineering as well as the chemical, pharmaceutical, and energy industries in the United States and worldwide.

At the time when his case was filed, our client has conducted 20 peer reviews for multiple highly distinguished journals; therefore exemplifies the degree to which he has established himself as a leader within the scientific community. In addition, his work has resulted in 11 peer-reviewed scientific articles which have accumulated 383 citations. In fact, these citations come from leading researchers from top universities and research groups from the United States and abroad, confirming the innovation his work has brought to the field, as well as demonstrating that his expertise and findings have been widely relied on by top researchers all over the world.

The following quote was made by a prominent professor, whose letter and the 5 others included in our client’s petition laid a solid foundation for him to secure EB-1B approval: “[Client]’s unique breadth of expertise has allowed for advanced combinations of techniques and tools that improve a wide array of processes for chemical and energy companies, improve the safety of their operations, and reduce their adverse impact on the environment. The technologies he has worked on in this context have been patented and are already used by major companies, including (…) and practically every major oil & gas and chemical company in the world, demonstrating the highly practical value of [Client]’s research”.

As a result of months of hard work and the engagement from our client, we filed a customized EB-1B petition on behalf of our client, and we are glad that his case was approved in just 7 days. With almost 15,000 approved I-140 cases in the bag, our firm is pleased to have helped yet another client get closer to obtaining a green card.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.